3-15644520-G-C
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_ModeratePP5_Moderate
The NM_001370658.1(BTD):c.604G>C(p.Asp202His) variant causes a missense change. The variant allele was found at a frequency of 0.00000658 in 152,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D202N) has been classified as Likely benign.
Frequency
Consequence
NM_001370658.1 missense
Scores
Clinical Significance
Conservation
Publications
- biotinidase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, ClinGen, Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001370658.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BTD | NM_001370658.1 | MANE Select | c.604G>C | p.Asp202His | missense | Exon 4 of 4 | NP_001357587.1 | ||
| BTD | NM_001281723.4 | c.604G>C | p.Asp202His | missense | Exon 4 of 4 | NP_001268652.2 | |||
| BTD | NM_001281724.3 | c.604G>C | p.Asp202His | missense | Exon 6 of 6 | NP_001268653.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BTD | ENST00000643237.3 | MANE Select | c.604G>C | p.Asp202His | missense | Exon 4 of 4 | ENSP00000495254.2 | ||
| BTD | ENST00000303498.10 | TSL:1 | c.604G>C | p.Asp202His | missense | Exon 5 of 5 | ENSP00000306477.6 | ||
| BTD | ENST00000427382.2 | TSL:4 | c.604G>C | p.Asp202His | missense | Exon 4 of 4 | ENSP00000397113.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152082Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152082Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74278 show subpopulations
ClinVar
Submissions by phenotype
Biotinidase deficiency Pathogenic:1
This variant disrupts the p.Asp222 amino acid residue in BTD. Other variant(s) that disrupt this residue have been observed in individuals with BTD-related conditions (PMID: 22698809, 26810761), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function. This missense change has been observed in individual(s) with biotinidase deficiency (PMID: 26810761). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 222 of the BTD protein (p.Asp222His). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at